Raffaele Califano, Antonio Passaro, Jiunn-Liang Tan, Ana Blasco, Juan Li, Clarissa Serodio Da Rocha Baldotto, Rosario García Campelo, Richu Sharma, Karen L. Reckamp, Sandeep H. Mashru, Toshiaki Takahashi, Pei-Ling Chu, Sandeep Kumar, Xuerui Luo, Jiarui Zhang, Joshua C. Curtin, Alexis B. Cortot. "Amivantamab plus chemotherapy vs chemotherapy in
            <i>EGFR</i>
            -mutant advanced NSCLC after disease progression on osimertinib: Outcomes by osimertinib resistance mechanisms in MARIPOSA-2.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8639